Articles published in
Int J Radiat Oncol Biol Phys
Retrieve available abstracts of 105 articles: HTML format
Single Articles
July 2025
SAMSON P, Robinson C How to Avoid Collapsing Under the Pressure of Managing Atelectasis During Lung
Cancer Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2025;122:785. PubMed
MEYER S, Hu YC, Rimner A, Mechalakos J, et al Deformable Image Registration Uncertainty-Encompassing Dose Accumulation for
Adaptive Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2025;122:818-826. PubMedAbstract available
CHUONG MD, Mittauer KE, Bassetti MF, Rojas C, et al Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy in One Fraction
(SMART ONE): A Multicenter, Single-Arm, Phase 2 Trial.
Int J Radiat Oncol Biol Phys. 2025;122:957-967. PubMedAbstract available
AKDEMIR EY, Herrera R, Gurdikyan S, Hodgson LC, et al Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for
Infradiaphragmatic Oligometastatic Disease: Disrupting the One-Size-Fits-All
Paradigm.
Int J Radiat Oncol Biol Phys. 2025;122:739-751. PubMedAbstract available
ZHOU L, Sun J, Xie C, Kang K, et al Low-dose radiotherapy concurrent with atezolizumab and chemotherapy as first-line
treatment for extensive-stage small-cell lung cancer: 3-year follow-up of a
multicenter, single-arm, phase 2 trial (MATCH).
Int J Radiat Oncol Biol Phys. 2025 Jul 1:S0360-3016(25)04508. PubMedAbstract available
June 2025
ZHANG SC, Kehayias CE, Guthier C, He J, et al Differential Impact of Left Ventricular Myocardium and Left Coronary Radiation
Dose with Incident Heart Failure and Coronary Events in Lung Cancer Radiotherapy.
Int J Radiat Oncol Biol Phys. 2025 Jun 25:S0360-3016(25)04493. PubMedAbstract available
ZHANG Y, Laine AM, Iyengar P, Westover KD, et al Concurrent and Consolidative Carboplatin Plus Nab-Paclitaxel or Paclitaxel in
Locally Advanced NSCLC: A Multicenter, Randomized Clinical Trial.
Int J Radiat Oncol Biol Phys. 2025;122:374-382. PubMedAbstract available
OHRI N, Bodner WR, Kabarriti R, Shankar V, et al Randomized Evaluation of the PET-Adjusted IMRT for NSCLC Trial (REPAINT).
Int J Radiat Oncol Biol Phys. 2025;122:365-373. PubMedAbstract available
May 2025
KEANE F, Daly M, Louie A, Harris J, et al Resistance is Futile: Stereotactic Body Radiation Therapy for Oligoprogressive
Non-small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys. 2025;122:1-4. PubMed
April 2025
ALFAIFI SA, Louie AV, Siva S, Guckenberger M, et al International Patterns of Practice for Stereotactic Ablative Radiotherapy for
Early-Stage Non-Small Cell Lung Cancer: Are We All in Sync?: Global patterns of
practice for SABR for early-stage NSCLC.
Int J Radiat Oncol Biol Phys. 2025 Apr 29:S0360-3016(25)00390. PubMedAbstract available
SIMONE CB 2ND, Amini A, Chetty IJ, Choi JI, et al American Radium Society Appropriate Use Criteria Systematic Review and
Guidelines on Reirradiation for Non-small Cell Lung Cancer Executive Summary.
Int J Radiat Oncol Biol Phys. 2025 Apr 2:S0360-3016(25)00259. PubMedAbstract available
PAN S, Chang CW, Tian Z, Wang T, et al Data-Driven Volumetric Computed Tomography Image Generation From Surface
Structures Using a Patient-Specific Deep Leaning Model.
Int J Radiat Oncol Biol Phys. 2025;121:1349-1360. PubMedAbstract available
HUANG YH, Li Z, Xiong T, Chen Z, et al Constructing Surrogate Lung Ventilation Maps From 4-Dimensional Computed
Tomography-Derived Subregional Respiratory Dynamics.
Int J Radiat Oncol Biol Phys. 2025;121:1328-1338. PubMedAbstract available
March 2025
COOKE SA, Belderbos JSA, Stam B, Reymen B, et al Esophageal Toxicity After Dose-Escalated Radiation Therapy for Stage II-III
Non-Small Cell Lung Cancer: A Secondary Analysis of the Phase 2 Randomized
ARTFORCE PET-Boost Trial.
Int J Radiat Oncol Biol Phys. 2025 Mar 28:S0360-3016(25)00228. PubMedAbstract available
MONTALVO SK, Lue B, Kakadiaris E, Ahn C, et al Global Longitudinal Strain: A Potential Non-invasive Tool for Early Detection of
Radiation-Induced Cardiac Dysfunction in Lung Cancer Patients Receiving Thoracic
Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2025 Mar 27:S0360-3016(25)00257. PubMedAbstract available
CHEN X, Meng F, Zhang P, Wang L, et al Establishing a deep learning model that integrates pre- and mid-treatment
computed tomography to predict treatment response for non-small cell lung cancer.
Int J Radiat Oncol Biol Phys. 2025 Mar 13:S0360-3016(25)00243. PubMedAbstract available
ALLEN SG, Schonewolf CA, Schipper MJ, Yin HM, et al Dosimetry and Toxicity Comparison of Three-Dimensional Conformal Radiation
Therapy and Intensity-Modulated Radiation Therapy in Locally Advanced Lung Cancer
Across a Large Statewide Quality Collaborative.
Int J Radiat Oncol Biol Phys. 2025 Mar 10:S0360-3016(25)00236. PubMedAbstract available
RIMNER A, Dejonckheere CS, Sahlmann J, Barth SA, et al Impact of Different Mediastinal Staging Modalities on Target Volume Delineation
in Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the
Multicenter Randomized PET-Plan Trial.
Int J Radiat Oncol Biol Phys. 2025 Mar 5:S0360-3016(25)00196. PubMedAbstract available
BROOKS FMD, Glenn MC, Hernandez V, Saez J, et al Is the Imaging Radiation Oncology Core Head and Neck Credentialing Phantom an
Effective Surrogate for Different Anatomic Sites?
Int J Radiat Oncol Biol Phys. 2025;121:811-821. PubMedAbstract available
February 2025
XIAO L, Li Y, Wang S, Fan L, et al Early prediction of radiation pneumonitis in patients with lung cancer treated
with immunotherapy through monitoring of plasma chemokines.
Int J Radiat Oncol Biol Phys. 2025 Feb 22:S0360-3016(25)00151. PubMedAbstract available
GAETA B, Eichholz JE, Walch H, Ilica AT, et al Intracranial disease control and survival among patients with KRAS-mutant lung
adenocarcinoma and brain metastases treated with SRS.
Int J Radiat Oncol Biol Phys. 2025 Feb 8:S0360-3016(25)00093. PubMedAbstract available
MA N, Ming X, Chen J, Jiang GL, et al Carbon ion radiotherapy with pencil beam scanning for stage III non-small cell
lung cancer: toxicity profiles, survival outcomes, and prognostic indicators.
Int J Radiat Oncol Biol Phys. 2025 Feb 5:S0360-3016(25)00094. PubMedAbstract available
SHIN YS, Yun JK, Jung J, Park JH, et al Comparison of Metastasectomy and Stereotactic Body Radiation Therapy for
Pulmonary Oligometastasis From Hepatocellular Carcinoma: A Propensity
Score-Weighted Analysis.
Int J Radiat Oncol Biol Phys. 2025;121:432-441. PubMedAbstract available
January 2025
LATIFI A, Roumeliotis M, Quirk S, Gardner UG, et al Brachytherapy Seed Placement by Robotic Bronchoscopy with Cone-Beam CT Guidance
for Peripheral Lung Cancer: A Human Cadaveric Feasibility Pilot.
Int J Radiat Oncol Biol Phys. 2025 Jan 25:S0360-3016(25)00078. PubMedAbstract available
NAGLER F, Vorbach S, Mohamed AA, Thaqi S, et al Pulmonary Stereotactic Body Radiotherapy of Oligometastatic Head-and-Neck
Squamous Cell Carcinoma - A multicenter retrospective study.
Int J Radiat Oncol Biol Phys. 2025 Jan 4:S0360-3016(24)03771. PubMedAbstract available
SCHELLENBERG D, Gabos Z, Duimering A, Debenham B, et al Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the
Randomized Phase 2 STOP Trial.
Int J Radiat Oncol Biol Phys. 2025;121:28-38. PubMedAbstract available
WANG E, Abdallah H, Snir J, Chong J, et al Predicting the 3-Dimensional Dose Distribution of Multilesion Lung Stereotactic
Ablative Radiation Therapy With Generative Adversarial Networks.
Int J Radiat Oncol Biol Phys. 2025;121:250-260. PubMedAbstract available
WANG Y, Dong X, Yan S, Liu B, et al Comparison of the Long-term Survival Outcome of Surgery versus Stereotactic Body
Radiation Therapy as Initial Local Treatment for Pulmonary Oligometastases from
Colorectal Cancer: A Propensity Score Analysis.
Int J Radiat Oncol Biol Phys. 2025;121:45-55. PubMedAbstract available
December 2024
BARRETT S, Zahid MU, Enderling H, Marignol L, et al Predicting Individual Tumor Response Dynamics in Locally Advanced Non-Small Cell
Lung Cancer Radiation Therapy: A Mathematical Modelling Study.
Int J Radiat Oncol Biol Phys. 2024 Dec 3:S0360-3016(24)03563. PubMedAbstract available
November 2024
KEANE FK, Yeap BY, Khandekar MJ, Lin JJ, et al Phase II trial of consolidative stereotactic body radiation therapy in patients
with metastatic oncogene-driven non-small cell lung carcinoma treated with
tyrosine kinase inhibitors.
Int J Radiat Oncol Biol Phys. 2024 Nov 20:S0360-3016(24)03515. PubMedAbstract available
DOHOPOLSKI M, Schmitt LG, Anand S, Zhang H, et al Exploratory Evaluation of Personalized Ultra-Fractionated Stereotactic Adaptive
Radiotherapy (PULSAR) with CNS-Active Drugs in Brain Metastases Treatment.
Int J Radiat Oncol Biol Phys. 2024 Nov 16:S0360-3016(24)03641. PubMedAbstract available
ZHAO X, Huang S, Lin H, Choi JI, et al A Novel Dose Rate Optimization Method to Maximize Ultrahigh-Dose-Rate Coverage of
Critical Organs at Risk Without Compromising Dosimetry Metrics in Proton Pencil
Beam Scanning FLASH Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2024;120:1181-1191. PubMedAbstract available
SIMONE CB 2ND Enhancing Outcomes in Locally Advanced Non-Small Cell Lung Cancer Through
Stereotactic Dose Escalation.
Int J Radiat Oncol Biol Phys. 2024;120:695-697. PubMed
SAMSON P, Harris JP Here Comes the Sun: Continuing to Refine the Treatment of Ultracentral Non-Small
Cell Lung Cancers.
Int J Radiat Oncol Biol Phys. 2024;120:678-680. PubMed
ZHANG S, Simard M, Lapointe A, Filion E, et al Evaluation of Radiation Dose Effect on Lung Function Using Iodine Maps Derived
From Dual-Energy Computed Tomography.
Int J Radiat Oncol Biol Phys. 2024;120:894-903. PubMedAbstract available
October 2024
WEISMAN M, Durm G, Shields MD, Hanna NH, et al Evaluation of Radiation Pneumonitis in a Phase II Study of Consolidation
Immunotherapy with Nivolumab and Ipilimumab or Nivolumab Alone Following
Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung
Cancer (NSCLC): Big Ten
Int J Radiat Oncol Biol Phys. 2024 Oct 25:S0360-3016(24)03450. PubMedAbstract available
SADDOUGHI SA, Kern R Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) Lining: We Can
All Have a Piece of the Pie.
Int J Radiat Oncol Biol Phys. 2024;120:357-358. PubMed
MCCALL NS, Higgins KA Toward the Optimal Delivery of Twice-Daily Thoracic Chemoradiation in
Limited-Stage Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys. 2024;120:343-344. PubMed
JABBOUR SK, Higgins KA, Yom SS, Goodman KA, et al Recapping Radiation Related Abstracts at ASCO 2024: A Commentary about the
Fundamental Role of Radiation Therapy in Esophageal and Lung Cancers.
Int J Radiat Oncol Biol Phys. 2024;120:309-314. PubMed
LI GJ, Tan H, Nusrat H, Chang J, et al Safety and Efficacy of Stereotactic Body Radiation Therapy for Ultra-central
Thoracic Tumors: A Single Center Retrospective Review.
Int J Radiat Oncol Biol Phys. 2024;120:359-369. PubMedAbstract available
KAMTAM DN, Binkley MS, Kapula N, Sadeghi C, et al First in Human Phase 1 Clinical Trial of Stereotactic Irradiation to Achieve Lung
Volume Reduction (SILVR) in Severe Emphysema.
Int J Radiat Oncol Biol Phys. 2024;120:345-356. PubMedAbstract available
September 2024
IGARASHI A, Onishi H, Shioyama Y, Matsumoto Y, et al Cost-Utility Analysis of Stereotactic Body Radiation Therapy Versus Surgery for
Patients With Stage I Non-small Cell Lung Cancer in Japan.
Int J Radiat Oncol Biol Phys. 2024 Sep 28:S0360-3016(24)03174. PubMedAbstract available
GENSHEIMER MF, Kotha NV, Vitzthum LK, Chin AL, et al A phase 2 single-arm trial of high-dose precision targeted radiotherapy added to
immunotherapy for patients with metastatic non-small cell lung cancer.
Int J Radiat Oncol Biol Phys. 2024 Sep 25:S0360-3016(24)03410. PubMedAbstract available
MACMANUS MP, Prins E, Xie J, Akhurst T, et al Dose-response relationships between radiation exposure, bone marrow function as
measured by (18)F-FLT PET, and lymphocyte counts during chemoradiation for
non-small cell lung cancer.
Int J Radiat Oncol Biol Phys. 2024 Sep 2:S0360-3016(24)03290. PubMedAbstract available
RANKINE LJ, Lu J, Wang Z, Kelsey CR, et al Quantifying Regional Radiation-Induced Lung Injury in Patients Using
Hyperpolarized (129)Xe Gas Exchange Magnetic Resonance Imaging.
Int J Radiat Oncol Biol Phys. 2024;120:216-228. PubMedAbstract available
August 2024
ZHANG Y, Iyengar P, Montalvo S, Westover KD, et al Concerning safety and efficacy of concurrent and consolidative durvalumab with
thoracic radiotherapy in PDL1-unselected stage III non-small cell lung cancer:
brief report.
Int J Radiat Oncol Biol Phys. 2024 Aug 13:S0360-3016(24)03177. PubMedAbstract available
TAN VS, Correa RJM, Nguyen TK, Louie AV, et al Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for
Early-Stage Non-Small Cell Lung Cancer (MISSILE): Long-Term Clinical Outcomes.
Int J Radiat Oncol Biol Phys. 2024 Aug 8:S0360-3016(24)03173. PubMedAbstract available
GRONBERG BH Are We Finally Ready to Implement Twice-Daily Thoracic Radiation Therapy in
Limited-Stage Small Cell Lung Cancer?
Int J Radiat Oncol Biol Phys. 2024;119:1391-1392. PubMed
LEAVITT RJ, Almeida A, Grilj V, Montay-Gruel P, et al Acute Hypoxia Does Not Alter Tumor Sensitivity to FLASH Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2024;119:1493-1505. PubMedAbstract available
PORTIER L, Daira P, Fourmaux B, Heinrich S, et al Differential Remodeling of the Oxylipin Pool After FLASH Versus Conventional
Dose-Rate Irradiation In Vitro and In Vivo.
Int J Radiat Oncol Biol Phys. 2024;119:1481-1492. PubMedAbstract available
July 2024
HARRIS JP, Samson P, Owen D, Siva S, et al Adapt or Perish: Adaptive RT for NSCLC.
Int J Radiat Oncol Biol Phys. 2024;119:1047-1051. PubMed
LIU W, Feng H, Taylor PA, Kang M, et al NRG Oncology and Particle Therapy Co-Operative Group Patterns of Practice Survey
and Consensus Recommendations on Pencil-Beam Scanning Proton Stereotactic Body
Radiation Therapy and Hypofractionated Radiation Therapy for Thoracic
Malignancies.
Int J Radiat Oncol Biol Phys. 2024;119:1208-1221. PubMedAbstract available
EDWARDS DM, Schonewolf CA, Rice JD, Schipper M, et al Phase II Trial Assessing Toxicity of Personalized Response-Based Radiation
Treatment in Patients with Locally Advanced Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys. 2024 Jul 4:S0360-3016(24)00749. PubMedAbstract available
Erratum to: Zeng Y, Liu Q, Wang Y, et al. CDK5 Activates Hippo Signaling to
Confer Resistance to Radiation Therapy Via Upregulating TAZ in Lung Cancer. Int J
Radiat Oncol Biol Phys 2020;108(3):758-769.
Int J Radiat Oncol Biol Phys. 2024;119:1030-1031. PubMed
Erratum to: Simone CB 2nd, Serebrenik AA, Gore EM, et al. Multicenter Phase 1b/2a
Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients with
Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy. Int J Radiat
Oncol Biol Ph
Int J Radiat Oncol Biol Phys. 2024;119:1029. PubMed
HARRISON N, Kang M, Liu R, Charyyev S, et al A Novel Inverse Algorithm To Solve the Integrated Optimization of Dose, Dose
Rate, and Linear Energy Transfer of Proton FLASH Therapy With Sparse Filters.
Int J Radiat Oncol Biol Phys. 2024;119:957-967. PubMedAbstract available
June 2024
NI J, Chen H, Yu L, Guo T, et al Predicting regional recurrence and prognosis in stereotactic body
radiotherapy-treated clinical stage I non-small cell lung cancer using a
radiomics model constructed with surgical data.
Int J Radiat Oncol Biol Phys. 2024 Jun 25:S0360-3016(24)00743. PubMedAbstract available
CASEY DL, Vogelius IR, Brodin NP, Roberts KB, et al Risk of Subsequent Neoplasms in Childhood Cancer Survivors After Radiation
Therapy: A PENTEC Comprehensive Review.
Int J Radiat Oncol Biol Phys. 2024;119:640-654. PubMedAbstract available
May 2024
LEE HI, Choi EK, Kim SS, Shin YS, et al Local Ablative Therapy Combined with Pembrolizumab in Patients with Synchronous
Oligometastatic Non-Small Cell Lung Cancer: A Recursive Partitioning Analysis.
Int J Radiat Oncol Biol Phys. 2024 May 24:S0360-3016(24)00674. PubMedAbstract available
April 2024
MIDRONI J, Salunkhe R, Liu Z, Chow R, et al Incorporating functional lung imaging (FLI) into radiation therapy planning in
patients with lung cancer: A systematic review and meta-analysis.
Int J Radiat Oncol Biol Phys. 2024 Apr 15:S0360-3016(24)00481. PubMedAbstract available
ZHANG Q, Fan S, Xu X, Du S, et al Efficacy and Toxicity of Moderately Hypofractionated Radiotherapy with Helical
TomoTherapy versus Conventional Radiotherapy in Patients with Unresectable Stage
III Non-Small-Cell Lung Cancer Receiving Concurrent Chemotherapy: A Multicentre,
Randomized
Int J Radiat Oncol Biol Phys. 2024 Apr 15:S0360-3016(24)00450. PubMedAbstract available
MEREDITH EG, Filion E, Faria S, Kundapur V, et al Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and
Efficacy Trial (SUNSET).
Int J Radiat Oncol Biol Phys. 2024 Apr 11:S0360-3016(24)00480. PubMedAbstract available
LOMBARDO J, Castillo E, Castillo R, Miller R, et al Prospective trial of Functional Lung Avoidance Radiation Therapy for Lung Cancer:
Quality of Life Report.
Int J Radiat Oncol Biol Phys. 2024 Apr 11:S0360-3016(24)00476. PubMedAbstract available
LEVIN N, Killingberg KT, Halvorsen TO, Danielsen S, et al Evaluation of radiotherapy treatment plans in a randomized phase II trial
comparing two schedules of twice-daily thoracic radiotherapy in limited stage
small-cell lung cancer.
Int J Radiat Oncol Biol Phys. 2024 Apr 5:S0360-3016(24)00475. PubMedAbstract available
VITZTHUM LK, Surucu M, Gensheimer MF, Kovalchuk N, et al BIOGUIDE-X: A First-in-Human Study of the Performance of Positron Emission
Tomography-Guided Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2024;118:1172-1180. PubMedAbstract available
HUANG HT, Brand DH, Fenwick JD, Hawkins MA, et al Immuno-chemoradiation for non-small cell lung cancer: A meta-analysis of factors
influencing survival benefit in combination trials.
Int J Radiat Oncol Biol Phys. 2024 Apr 1:S0360-3016(24)00449. PubMedAbstract available
March 2024
KIM KH, Kang N, Song SY, Kim HJ, et al Safety and efficacy of HL301 in radiation pneumonitis in patients with
unresectable non-small cell lung cancer receiving curative concurrent
chemoradiotherapy: A multicenter, randomized, double-blinded, placebo-controlled,
phase IIa clinical trial.
Int J Radiat Oncol Biol Phys. 2024 Mar 31:S0360-3016(24)00447. PubMedAbstract available
FAROOQI AS, Yoder AK, Lin HY, Pasalic D, et al SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for
Patient Selection.
Int J Radiat Oncol Biol Phys. 2024;118:971-978. PubMedAbstract available
LUCIA F, Bourhis D, Pinot F, Hamya M, et al Prediction of Acute Radiation-Induced Lung Toxicity After Stereotactic Body
Radiation Therapy Using Dose-Volume Parameters From Functional Mapping on Gallium
68 Perfusion Positron Emission Tomography/Computed Tomography.
Int J Radiat Oncol Biol Phys. 2024;118:952-962. PubMedAbstract available
LIU YC, Schmidt RO, Kapadia NS, Phillips JD, et al Disparities in access to multidisciplinary cancer consultations and treatment for
early-stage non-small cell lung cancer patients: A SEER-Medicare analysis.
Int J Radiat Oncol Biol Phys. 2024 Mar 13:S0360-3016(24)00426. PubMedAbstract available
WALLS GM, Mistry H, Barlesi F, Bezjak A, et al Long-term outcomes after concurrent once- or twice-daily chemoradiation in
limited-stage small-cell lung cancer: a brief report from the CONVERT trial.
Int J Radiat Oncol Biol Phys. 2024 Mar 11:S0360-3016(24)00382. PubMedAbstract available
YAN W, Ren Z, Chen X, Zhang R, et al Potential role of lymphocyte CD44 in determining treatment selection between
stereotactic body radiotherapy and surgery for early-stage non-small-cell lung
cancer.
Int J Radiat Oncol Biol Phys. 2024 Mar 4:S0360-3016(24)00356. PubMedAbstract available
SHUJA M, Owen D What if Perioperative Therapy for Non-Small Cell Lung Cancer Renders Someone
Inoperable?
Int J Radiat Oncol Biol Phys. 2024;118:587. PubMed
FARLEY A, Nelson B Neoadjuvant Chemoimmunotherapy for Initially Resectable Non-Small Cell Lung
Cancer: Queen's Gambit or CheckMate?
Int J Radiat Oncol Biol Phys. 2024;118:585-586. PubMed
February 2024
BASCHNAGEL AM, Flakus MJ, Wallat EM, Wuschner AE, et al A Phase 2 Randomized Clinical Trial Evaluating 4DCT Ventilation-based Functional
Lung Avoidance Radiotherapy for Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00327. PubMedAbstract available
WILLIAMS TM, Miller E, Welliver M, Brownstein J, et al A Phase II Trial of Primary Tumor SBRT Boost Prior to Concurrent Chemoradiation
for Locally-Advanced Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00324. PubMedAbstract available
HAN C, Qiu J, Bai L, Liu T, et al Pneumonitis risk after chemoradiotherapy with and without immunotherapy in
patients with locally advanced non-small cell lung cancer: A systematic review
and meta-analysis.
Int J Radiat Oncol Biol Phys. 2024 Feb 13:S0360-3016(24)00298. PubMedAbstract available
KIM H, Lee E, Cho H, Kim E, et al Five-Day Spacing of Two Fractionated Ablative Radiotherapies Enhances Antitumor
Immunity.
Int J Radiat Oncol Biol Phys. 2024;118:498-511. PubMedAbstract available
January 2024
WANG J, Liu Y, Wu D, Tian C, et al OTUB1 targets CHK1 for deubiquitinating and stabilizing to facilitate lung cancer
progression and radioresistance.
Int J Radiat Oncol Biol Phys. 2024 Jan 22:S0360-3016(24)00246. PubMedAbstract available
TRAN PT, Mouw KW SABR Today . . . and Tomorrow?
Int J Radiat Oncol Biol Phys. 2024;118:11. PubMed
WRIGHT JL, Bazan JG Time to Reconsider the Role of Diagnostic Chest Computed Tomography in
Early-Stage Breast Cancer?
Int J Radiat Oncol Biol Phys. 2024;118:104-106. PubMed
CHEN Y, Pahlavian SH, Jacobs P, Neupane T, et al Systematic Evaluation of the Impact of Lung Segmentation Methods on 4-Dimensional
Computed Tomography Ventilation Imaging Using a Large Patient Database.
Int J Radiat Oncol Biol Phys. 2024;118:242-252. PubMedAbstract available
December 2023
BARTOLOMEO V, Cortiula F, Hendriks LEL, De Ruysscher D, et al A Glimpse Into the Future for Unresectable Stage III Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys. 2023 Dec 27:S0360-3016(23)08126. PubMed
RIMNER A, Gelblum DY, Wu AJ, Shepherd AF, et al Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-small
Cell Lung Cancer - A Phase I Dose Escalation Trial.
Int J Radiat Oncol Biol Phys. 2023 Dec 26:S0360-3016(23)08252. PubMedAbstract available
RAN X, Wu BX, Shi M, Song L, et al CRISPR screen of druggable targets in small cell lung cancer identified ATM
inhibitor (AZD1390) as a radiosensitizer.
Int J Radiat Oncol Biol Phys. 2023 Dec 15:S0360-3016(23)08245. PubMedAbstract available
VAIOS EJ, Shenker RF, Hendrickson PG, Wan Z, et al Long-term Intracranial Outcomes with Combination Dual Immune-Checkpoint Blockade
and SRS in Patients with Melanoma and NSCLC Brain Metastases.
Int J Radiat Oncol Biol Phys. 2023 Dec 12:S0360-3016(23)08234. PubMedAbstract available
BASSETTI MF, Morris BA, Sethakorn N, Lang JM, et al Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of
Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a
Phase Ib Trial.
Int J Radiat Oncol Biol Phys. 2023 Dec 8:S0360-3016(23)08166. PubMedAbstract available
DUDAS D, Saghad PG, Dilling TJ, Perez BA, et al Deep Learning-Guided Dosimetry for Mitigating Local Failure of Non-Small Cell
Lung Cancer Patients Receiving SBRT.
Int J Radiat Oncol Biol Phys. 2023 Dec 4:S0360-3016(23)08185. PubMedAbstract available
SAFAVI AH, Palma DA, Giuliani ME Beyond the HILUS Trial: How Can We Improve the Safety of SABR for Ultracentral
Thoracic Tumors?
Int J Radiat Oncol Biol Phys. 2023;117:1232-1235. PubMed
SIVA S, Staehler M The Right Tool for the Job: The Knife, the SABR, or Fire and Ice?
Int J Radiat Oncol Biol Phys. 2023;117:1047. PubMed
AHN J, Yeghiaian-Alvandi R, Hegi-Johnson F, Browne LH, et al SABR for Early Non-Small Cell Lung Cancer: Changes in Pulmonary Function,
Dyspnea, and Quality of Life.
Int J Radiat Oncol Biol Phys. 2023;117:1213-1221. PubMedAbstract available
LINDBERG S, Grozman V, Karlsson K, Onjukka E, et al Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From
Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors.
Int J Radiat Oncol Biol Phys. 2023;117:1222-1231. PubMedAbstract available
LEE SH, Geng H, Arnold J, Caruana R, et al Interpretable Machine Learning for Choosing Radiation Dose-volume Constraints on
Cardio-pulmonary Substructures Associated with Overall Survival in NRG Oncology
RTOG 0617.
Int J Radiat Oncol Biol Phys. 2023;117:1270-1286. PubMedAbstract available
November 2023
MA J, Li Y, Yu H, Zhang J, et al The Role of Thoracic Vertebral Body Dosimetry in Minimizing Acute Hematologic
Toxicities of Non-Small Cell Lung Cancer Patients Receiving Lung Radiotherapy and
Immunotherapy.
Int J Radiat Oncol Biol Phys. 2023 Nov 29:S0360-3016(23)08165. PubMedAbstract available
VALDES G, Scholey J, Nano T, Gennatas ED, et al Predicting the impact of proton beam therapy technology on pulmonary toxicities
for locally advanced lung cancer patients enrolled on the Proton Collaborative
Group prospective clinical trial.
Int J Radiat Oncol Biol Phys. 2023 Nov 22:S0360-3016(23)08154. PubMedAbstract available
RAMESH S, Cifci A, Javeri S, Minne R, et al MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified
Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys. 2023 Nov 16:S0360-3016(23)08139. PubMedAbstract available
RITTER AR, Miller ED No Regrets About SABR for NETs.
Int J Radiat Oncol Biol Phys. 2023;117:786. PubMed
OMIDI A, Weiss E, Rosu-Bubulac M, Thomas G, et al Quantitative analysis of radiotherapy-induced cardiac and aortic sequelae in lung
cancer patients via magnetic resonance imaging: A pilot study.
Int J Radiat Oncol Biol Phys. 2023 Nov 9:S0360-3016(23)08045. PubMedAbstract available
KUIPERS ME, van Doorn-Wink KCJ, Hiemstra PS, Slats AM, et al Predicting radiation-induced lung injury in lung cancer patients - challenges and
opportunities: Predicting radiation-induced lung injury.
Int J Radiat Oncol Biol Phys. 2023 Nov 2:S0360-3016(23)08049. PubMedAbstract available
HEGI-JOHNSON F, Rudd SE, Wichmann CW, Akhurst T, et al PD-L1 Positron Emission Tomography Imaging in Patients With Non-Small Cell Lung
Cancer: Preliminary Results of the ImmunoPET Phase 0 Study.
Int J Radiat Oncol Biol Phys. 2023;117:675-682. PubMed
October 2023
GAUDREAULT M, Bucknell N, Woon B, Kron T, et al Dose-response relationship between radiotherapy and loss of lung perfusion
comparing positron emission tomography and dual-energy computed tomography in
non-small cell lung cancer.
Int J Radiat Oncol Biol Phys. 2023 Oct 30:S0360-3016(23)08047. PubMedAbstract available
FRIEDES C, Iocolano M, Lee SH, Li B, et al Patterns of Failure, Low Volume Relapse, and Subsequent Ablative Management in
Locally Advanced Non-Small Cell Lung Cancer Treated with Definitive
Chemoradiation and Consolidation Immune Checkpoint Inhibitors: Patterns of
Failure for after PACIFIC.
Int J Radiat Oncol Biol Phys. 2023 Oct 20:S0360-3016(23)08010. PubMedAbstract available
EDWARDS DM, Sankar K, Alseri A, Jiang R, et al Pneumonitis after chemoradiation and adjuvant durvalumab in stage III
non-small-cell lung cancer.
Int J Radiat Oncol Biol Phys. 2023 Oct 2:S0360-3016(23)07971. PubMedAbstract available
September 2023
LIU F, Ververs JD, Farris MK, William Blackstock A Jr, et al Optimal Radiotherapy Fractionation Regimens for Early-Stage Non-Small-Cell Lung
Cancer.
Int J Radiat Oncol Biol Phys. 2023 Sep 19:S0360-3016(23)07929. PubMedAbstract available
MENG Y, Sun H, Wang S, Yang H, et al Treatment-Related Pneumonitis of EGFR Tyrosine Kinase Inhibitors Plus Thoracic
Radiotherapy in Patients with Non-Small Cell Lung Cancer: A Systematic Review and
Meta-Analysis.
Int J Radiat Oncol Biol Phys. 2023 Sep 14:S0360-3016(23)07917. PubMedAbstract available